Open Access

Dexmedetomidine preconditioning protects against lung injury induced by ischemia-reperfusion through inhibition of autophagy

  • Authors:
    • Wei Zhang
    • Jiaqiang Zhang
  • View Affiliations

  • Published online on: June 16, 2017     https://doi.org/10.3892/etm.2017.4623
  • Pages: 973-980
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to evaluate the role of autophagy in the protective effect of dexmedetomidine in lung injury caused by ischemia-reperfusion (IR) in rats. In total 48 adult male Sprague‑Dawley rats were randomly divided into 6 groups (n=8) as follows: i) Sham group; ii) the IR group; iii) IR + 1 µg/kg dexmedetomidine preconditioning group (pre‑LD); iv) IR + 10 µg/kg dexmedetomidine preconditioning group (pre‑HD); v) IR + 1 µg/kg dexmedetomidine postconditioning group (post‑LD); and vi) IR + 10 µg/kg dexmedetomidine postconditioning group (post‑HD). After the rats were anesthetized, the hilum of the left lung was occluded with a non‑invasive microvascular clip for 30 min to induce ischemia. The clip was then removed and the left lung was allowed to regain ventilation and blood for 2 h. The rats were then sacrificed, the left lung removed and the wet/dry (W/D) lung weight ratio was determined. Pathological changes to the lungs were evaluated by light and transmission electron microscopy. Furthermore, the rate of lung cell apoptosis was determined by the TUNEL assay. The expression of hypoxia‑inducible factor 1α (HIF‑1α), Bcl‑2/adenovirus E1B 19‑kDa interacting protein 3 (BNIP3), BNIP3 like (BNIP3 L) and microtubule‑associated protein 1A/1B light chain 3B (LC3II) was determined by western blotting. Compared with the sham group, a significant increase in the W/D lung weight ratio, and malondialdehyde (MDA), BNIP3, BNIP3 L and LC3II levels were observed in the IR group, and HIF‑1α levels and superoxide dismutase (SOD) activity were decreased. Furthermore, the W/D ratio was lower in the pre‑LD and pre‑HD groups than in the IR group. Additionally, SOD activity was significantly higher and MDA expression was significantly lower in the pre‑LD and pre‑HD groups compared with the IR group. BNIP3, BNIP3 L and LC3II protein levels were significantly lower in the pre‑LD and pre‑HD groups compared with the IR group, while HIF‑1α was notably upregulated in the pre‑LD and pre‑HD groups compared with the IR group. In conclusion, the results of the present study indicate that dexmedetomidine preconditioning protects against lung injury induced by IR through inhibition of autophagy and apoptosis.
View Figures
View References

Related Articles

Journal Cover

August-2017
Volume 14 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang W and Zhang J: Dexmedetomidine preconditioning protects against lung injury induced by ischemia-reperfusion through inhibition of autophagy. Exp Ther Med 14: 973-980, 2017.
APA
Zhang, W., & Zhang, J. (2017). Dexmedetomidine preconditioning protects against lung injury induced by ischemia-reperfusion through inhibition of autophagy. Experimental and Therapeutic Medicine, 14, 973-980. https://doi.org/10.3892/etm.2017.4623
MLA
Zhang, W., Zhang, J."Dexmedetomidine preconditioning protects against lung injury induced by ischemia-reperfusion through inhibition of autophagy". Experimental and Therapeutic Medicine 14.2 (2017): 973-980.
Chicago
Zhang, W., Zhang, J."Dexmedetomidine preconditioning protects against lung injury induced by ischemia-reperfusion through inhibition of autophagy". Experimental and Therapeutic Medicine 14, no. 2 (2017): 973-980. https://doi.org/10.3892/etm.2017.4623